USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Sartorius Stedim Biotech Gmbh

USPTO PatentsView assignee record - 237 granted patents across 88 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C12M (APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERME).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

237

Total patents granted

CPC technology areas

13.4

Avg claims per patent

+1%

5-year filing velocity

The verdict

Sartorius holds 237 US patents across 88 technology areas, rank #1,725 of 50,000 tracked assignees.

#1,725
of 50,000 US assignees by volume: Top 5%
by Innovation Score (58.3/100): 13.4
avg claims per patent: +1%
filing velocity, last 5 yrs

Portfolio overview

Sartorius Stedim Biotech Gmbh has been granted 237 US utility patents between 2015 and 2025, placing Sartorius Stedim Biotech Gmbh at rank #1,725 across all assignees tracked by PlainPatent. This portfolio spans 88 distinct Cooperative Patent Classification (CPC) subclasses, averaging 13.4 claims per patent with primary concentration in C12M (APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERME). As a Foreign Corporation, Sartorius Stedim Biotech Gmbh is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Sartorius sits between AVL LIST Gmbh (237 patents, rank #1,721) and ALPS Electric Co., Ltd. (236 patents, rank #1,729) - the closest US assignees by grant volume. The composite Innovation Score of 58.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 119 grants, compared with 118 in the 2015–2019 window, a +1% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Sartorius Stedim Biotech Gmbh's 13.4 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 88 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Sartorius Stedim Biotech Gmbh against peers pursuing similar technology classes.

AVL LIST

237
Faraday & Future

237
Hitachi Maxell

237
Sicpa Holding

237
Tsubakimoto Chain

237
University of Lou…

237
Sartorius Stedim… ◀

237
AAC Microtech (Ch…

236
ALPS Electric

236

What this shows Sartorius holds 237 patents at rank #1,725, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Sartorius

By rank, the assignees closest to #1,725 in granted patent volume.

Leaders in C12M (Apparatus FOR Enzymology OR Microbiology)

Other assignees with the most granted patents in Sartorius's primary technology class.

Sartorius's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

58 Top 5% higher than 95% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Sartorius Stedim Biotech Gmbh patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	25	10.5%
2016	17	7.2%
2017	21	8.9%
2018	21	8.9%
2019	34	14.3%
2020	16	6.8%
2021	20	8.4%
2022	20	8.4%
2023	22	9.3%
2024	25	10.5%
2025	16	6.8%

Which technologies does Sartorius Stedim Biotech Gmbh patent most?

C12M - APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS 84

B01D - SEPARATION 81

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 41

B01F - MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING 37

B01L - CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE 25

B01J - CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS 15

Y10T - TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION 15

C07K - PEPTIDES 12

A61L - METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES 12

B65D - CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES 11

F16L - PIPES; JOINTS OR FITTINGS FOR PIPES; SUPPORTS FOR PIPES, CABLES OR PROTECTIVE TUBING; MEANS FOR THERMAL INSULATION IN GENERAL 11

B29C - SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING 10

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 9

G01M - TESTING STATIC OR DYNAMIC BALANCE OF MACHINES OR STRUCTURES; TESTING OF STRUCTURES OR APPARATUS, NOT OTHERWISE PROVIDED FOR 9

F16K - VALVES; TAPS; COCKS; ACTUATING-FLOATS; DEVICES FOR VENTING OR AERATING 7

Top 15 of 88 technology areas

Patent Moat Analysis

Portfolio Volume Moderate

Tech Breadth Multi-domain

Claim Depth Standard

Velocity Growing

Where it ranks

Overall rank by patents

#1,725

Across all tracked assignees

Innovation Score

58.3 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Sartorius Stedim Biotech Gmbh hold?

Sartorius Stedim Biotech Gmbh holds 237 US granted patents filed between 2015 and 2025, spanning 88 technology areas.

What is Sartorius Stedim Biotech Gmbh's Innovation Score?

Sartorius Stedim Biotech Gmbh has an Innovation Score of 58.3 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Sartorius Stedim Biotech Gmbh focus on?

Sartorius Stedim Biotech Gmbh's top technology area is C12M (APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS) with 84 patents. The company has filed patents in 88 CPC subclasses total.

Is Sartorius Stedim Biotech Gmbh's patent filing rate increasing or decreasing?

Sartorius Stedim Biotech Gmbh's recent filing velocity is +1% compared to the prior five-year period. The company is maintaining or growing its patent output.

What does claim depth mean for Sartorius Stedim Biotech Gmbh's patents?

Sartorius Stedim Biotech Gmbh's patents average 13.4 claims each. This falls within the standard range, providing solid legal coverage.

How is the Sartorius Stedim Biotech Gmbh patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Sartorius's 237 grants land it in the top 5% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Sartorius ranks #1,725 of 50,000. Top 50 holders
Most of this portfolio concentrates in C12M - see who else leads that technology area. C12M leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.